ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996

In Brief: Pasche Named Director of Wake Forest Cancer Center

March 7, 2014

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

November 3, 1995

NCI prepares for third hearing on conflicts of interest.

June 18, 2004

Guest Editorial: Chernobyl Doctor’s Notes From Fukushima

April 1, 2011